Skip to main content

Diabetes Mellitus: Metabolic Syndrome and Role of Incretins!

 METABOLIC SYNDROME AND INCRETIN EFFECT

METABOLIC SYNDROME:

"Insulin resistance has been associated with a number of other cardiovascular risks, including Abdominal obesity, Hypertension, Dyslipidemia, Hypercoagulation, and Hyperinsulinemia. The clustering of these risk factors has been termed as Metabolic syndrome."

The most widely used criteria to define metabolic syndrome were established by the National Cholesterol Education Program Adult Treatment Panel III Guidelines.



INCRETIN EFFECT

  • Incretins: are a group pf metabolic hormone that stimulate a decrease in blood Glucose levels.
  • Incretin hormones are: GLP-1, GIP.
  • Incretins are gut hormones that are secreted from entero-endocrine cells into blood within minutes after eating (present in GIT, Stomach, and Pancreas).
  • A great deal of research is occurring today to develop compounds that enhance the incretin effect, either by mimicking its action or y enabling incretin hormones, to remain physiologically active for longer periods of time.

As early as the late 1960s, Perley and others observed that insulins response to oral glucose exceeded that of intravenous glucose administration. It was conducted that factors in the gut, or incretins affected the release of insulin after a meal is consumed.

  • When nutrients enter the stomach and intestine, incretin hormones are released which stimulates Insulin secretion. 
  • GLP-1 & GIP are two major incretin hormones; with GLP-1 being studied the most.

GLP-1 is secreted by the L-cells of the ileum and colon primarily. GLP-1 secretion is caused by the endocrine and neural signals started when nutrients enter the gastrointestinal tract. A glucose dependent release if insulin occurs, and the dipeptidyl peptidase (DDP-4) enzyme cleaves GLP-1 rapidly to an inactive metabolite. Other glucose lowering effects of GLP-1 include suppression of glucagon, slowing gastric emptying, and increasing satiety.

GIP is secreted by the K-cells.

Labels:

Comments

Post a Comment

Popular posts from this blog

Drug-Induced Ototoxicity!

 DRUG-INDUCED OTOTOXICITY What is drug Induced Ototoxicity? Drug-Induced ototoxicity can affect hearing (auditory or cochlear function0, balance (vestibular function) depending on the drug. Drugs of almost every class have been reported to produce tinnitus (sounds in ear), as have placebos. The following agents are associated with measurable changes in hearing or vestibular defect when administered systemically. 1. AMINOGLYCOSIDES: Aminoglycosides antibiotics can cause cochlear or vestibular toxicities. Cochlear toxicity: occurs as progressive hear loss, starting with highest tones and advancing to lower tones. Thus, considerable damage can occur before the patient recognizes it. S ymptoms of Vestibular damage : include;  Dizziness Vertigo Ataxia Both forms of ototoxicity are bilateral and potentially reversible, but permanent damage is common and can progress even after discontinuation of aminoglycosides. Clinically detectable ototoxicity in as many as 5% patients. Most amin...
Post a Comment
Read more

Diabetes Mellitus: Non-Pharmacological Therapy--MNT!

 NON PHARMACOLOGICAL THERAPY  MNT Glycemic Index Dietary supplements Weight measurements Physical Activity Psychological assessment Immunizations 1. MEDICAL NUTRITION THERAPY (MNT)  " Medical Nutrition Therapy (MNT) is a term used by the ADA to describe the optimal condition of caloric intake with other aspects of diabetes therapy (Insulin, Exercise, Weight loss)". The ADA has issued recommendations for three types of MNT: Primary prevention measures of MNT are directed at preventing or delaying the onset of type 2 Diabetes in high-risk individuals (obese or with pre-diabetes) by promoting weight reduction. Secondary prevention measures of MNT are directed at preventing or delaying-related complications in diabetic individuals by improving glycemic control. Tertiary prevention measures of MNT are directed at managing diabetes-related complications (cardiovascular disease, neuropathy) in diabetic individuals. Despite the popular notion, there is not any " Diabetic diet...
Post a Comment
Read more

PNEUMONIA- Its Etiology, Pathophysiology, Classification and Severity Assessment Method!

 PNEUMONIA Definition: "Pneumonia is an infection of pulmonary parenchyma". (Harrison)                                                    OR "Pneumonia is defined as an acute respiratory illness associated with recently developed radiological pulmonary shadowing which may be segmental, lobar or multilobar". (Davidson) Etiology: Microorganisms gain excess to the lower respiratory tract in several ways: Aspiration from the oropharynx (most common). Inhalation of contaminated droplets. Hematogenous spread. Contiguous extension. Pathophysiology of Pneumonia: Pneumonia results from proliferation of microbial pathogens at the alveolar level and the hosts response to these microorganisms.  Defensive Mechanisms against Pneumonia: The defensive mechanism against pneumonia involve: Branching architecture of tracheobronchial tree. Muco-ciliary clearance. Local...
Post a Comment
Read more